Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450951 · ClinicalTrials.gov registry record · NA
A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals
A NA study of Environmental Exposure, sponsored by Million Marker Wellness.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06450951: Active NA study of Environmental Exposure, sponsored by Million Marker Wellness.
NCT06450951 is a NA study of Environmental Exposure that is active but no longer recruiting, run by Million Marker Wellness. The registered enrollment target is 600 participants, above the 244-participant average among 13 other Environmental Exposure trials with a reported enrollment target (146% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06450951, a NA study of Environmental Exposure, is active but no longer recruiting, sponsored by Million Marker Wellness.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a personalized biomonitoring report-back and educational intervention in child-bearing aged men and women can reduce endocrine disrupting chemicals (EDCs) measured in urine, increase participants' understanding of environmental health (environmental health literacy; EHL), increase their readiness and behaviors to reduce exposures, and improve their well-being. The intervention includes EDC testing and exposure report-back, a self-directed online interactive curriculum with access to live coaches, and an online forum. The investigators hypothesize that the intervention will be more effective than EDC testing and report-back alone at reducing EDC exposures (behavior change and metabolite concentrations), as well as increasing EHL, readiness to reduce exposures, and well-being.
Primary Outcome
Urinary EDC metabolites include bisphenols, phthalates, parabens and oxybenzone
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Urinary EDC metabolite testing
- BEHAVIORAL Educational curriculum
Study Locations (1)
Nevada
- Renown Health - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-05-23 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What the registry record for NCT06450951 still lists
NCT06450951 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 244-participant average among 13 other Environmental Exposure trials with a reported enrollment target (146% higher).
The record links to 1 condition, with Environmental Exposure appearing as the primary indexed condition, and to 2 interventions - of which Urinary EDC metabolite testing is the first listed.
NCT06450951 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06450951 about?
NCT06450951 is a clinical study titled "A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals". The goal of this clinical trial is to learn if a personalized biomonitoring report-back and educational intervention in child-bearing aged men and women can reduce endocrine disrupting chemicals (EDCs) measured in urine, increase participants' understanding of environmental health (environmental hea...
What is the current status of trial NCT06450951?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-05-23. Estimated completion is 2026-08-01.
What conditions does trial NCT06450951 study?
This clinical trial studies the following conditions: Environmental Exposure.
What interventions are being tested in trial NCT06450951?
The interventions under investigation include: Urinary EDC metabolite testing (DIAGNOSTIC_TEST), Educational curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT06450951?
This trial is sponsored by Million Marker Wellness, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06450951 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Environmental Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06450951's enrollment target sits among peer trials
600 2nd of 13 the highest of 13 other Environmental Exposure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Environmental Exposure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing and Addressing Community Exposures to Environmental Contaminants
RECRUITING · NA
-
Childhood Activities Nutrition and Development Oversight
RECRUITING · NA
-
Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire
RECRUITING · NA
-
The IGNITE Study on Concentrated Investment in Black Neighborhoods
ACTIVE NOT RECRUITING · NA
-
Sleep Improvement Via Environmental Smart Temperature Adjustments
ACTIVE NOT RECRUITING · NA
-
The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI